The human amylin is a pancreatic peptide hormone cosecreted with amylin and found in hyperhormonemic state along with insulin in subclinical diabetes. Amylin has been associated with the pathology of type 2 diabetes, particularly due to its ability to assembly into toxic oligomers and amyloid speciments. On the other hand, some variants such as murine amylin has been described as non amyloidogenic, either in vitro or in vivo. Recent data have demonstrated the amyloid propensity of murine amylin and the therapeutic analogue pramlintide, suggesting a universality for amylin amyloidosis. Here we report the amyloidogenesis of murine amylin, which showed lower responsivity to the fluorescent probe thioflavin T compared to human amylin, but presented highly organized fibrilar amyloid material. The aggregation of murine amylin also resulted in the formation of cytotoxic specimens, as evaluated in vitro in INS-1 cells.
Introduction
The existence of amyloid deposits in pancreas has been known for over a century [1] .
More recently, the nature of these depots in pancreas of diabetic human and cats were confirmed to be amylin aggregates [2, 3] . The lack of detectable amyloid material in some other animals possessing proline in specific positions of their amylin [4] raised a possible role of this imino acid in hampering the formation of amyloid assemblies, most likely due to the beta-disrupting character of prolines [5] . Such discovery prompted the development of the triple proline (Pro 25, 28, 29 ) human amylin analogue known as pramlintide, which entered the pharmaceutical market in 2005 [6] . Formulated in acetate pH 4.0, pramlintide displays chemical and physicochemical stability, although the intrinsic propensity for fast amyloid aggregation is still dominant in higher pH [7] . Murine amylin is also prone to amyloid aggregation in vitro [8, 9] , which collectively suggest an universal feature of amylin analogues.
The amylin analogue from pufferfish has recently been described as capable to aggregate into amyloid material although not detectable by thioflavin T (ThT) [10] . In conjunction these data indicate that despite the propensity of these amylin analogues to assembly into amyloid material, quantitative detection might have been an historical issue, both in vitro and in biological specimens. In fact, previous studies have also reported amyloid-related properties for murine amylin in vitro [11] [12] [13] . Some other ex vivo studies have also detected oligomer-like immunoreactive material (OLIM) [14] and congo-red birefringent fibers [15] in the endocrine pancreas of rodents, though considered of minor importance.
We raised the hypotheses weather it would exist a universal propensity for the oligomeric assembly and amyloid formation of amylin analogues, whose detection would be hampered both by ligands such as buffers as observed for murine amylin [9] and pramlintide [7] , among other technical details. In this work we report the investigation of the toxic nature of murine amylin and the natural abundance of oligomer-like immunoreactive material in pancreatic islets of nontrangenic mice . analysed with the empirical four-parameters sigmoid function with Sigma Plot 12.5 (Systat Software, Inc., CA, USA) as previously described [7, 9] .
MATERIAL AND METHODS

Materials
Transmission electron microscopy (TEM) -Aliquots of 5 µL from the aggregation kinetic assays were applied to 300 mesh, Formvar-coated Cu grids, the excess removed and the grid was subjected to negative stain with 2% uranyl acetate, pH 4.8, for about 30 s protected from light, the excess removed and the grid was air-dried. The stained samples were observed in a transmission electron microscope (Tecnai G2, FEI; DIMAV-INMETRO) operating at 80 to 120 kV.
Immunochemistry was performed at room temperature by applying aliquots aggregation kinetic assays onto 300 mesh, Formvar-coated Cu grids, the excess removed, blocked with blocking buffer (927-40000 Odyssey® Blocking Buffer, PBS-based), treated with primary antibodies OC (anti amyloid fibril-like material; Cat #AB2286, Merck-Millipore) or A11 (anti prefibrillar oligomer-like material; Cat #AB9234, Merck-Millipore), washed 2 times with blocking buffer, treated with secondary antibody immunogold (10 nm particles) and washed for 6 times, and stained with uranyl acetate. The stained samples were observed in a transmission electron microscope (Tecnai G2, FEI) operating at 80 to 120 kV. Biosciences; CENABIO-UFRJ) using the intensity set #5 for human amylin and the set #7 for murine amylin (due to its lower signal compared to results performed in parallel with the more immune responsive human amylin).
Immunodetection
Immunohistochemistry -Swiss male mice (CEMIB-UNICAMP-Campinas) were housed in a mini-isolators in ventilated racks (VentiLife 112, Alesco, Brazil) within a temperature-controlled room with a light-dark cycle of 12 h. Water and standard chow diet (Biobase, Cat #9301, Brazil) were available ad libitum. 12 weeks-old mice were fasted for 4 h and euthanized by decaptation.
Pancreatic tissues were collected and fixed in 4 % paraformaldehyde, embedded in paraffin and cut in 5 µm sections for further immunohistochemistry with anti-murine amylin (in-house derived, from rabbits, produced by EJ-APC) and A11 (anti prefibrillar oligomer-like material;
Cat #AB9234, Merck-Millipore). Alexa633-conjugated α-rabbit (1:400, Invitrogen, USA) was employed as secondary antibody. Unspecific binding was monitored using as primary antibody non-immune rabbit serum. Paraffin sections were dewaxed in xylol, hydrated in graded ethanol and distilled water. The sections were then heated in 10 mM sodium citrate buffer (pH 6.0) for 10 min in 700W microwave oven followed by 30 min to cool down to room temperature to retrieve the antigens. After blocking with PBS solution containing 5% bovine serum albumin, 0.25% Triton X-100 and 10% normal goat serum, sections were incubated overnight in a humid chamber (4°C) with the respective primary antibody, followed by 3 washes (5 min each), and then incubated with secondary antibodies diluted in the same blockage solution for 90 min at (experiments of 24h incubation) or 5 x 104 (48h incubation) per well and allowed to attach for 15h. Thereafter cells were exposed to amylin at 50 µM from the aggregation assays. Control assays were INS-1 cells and vehicle only, in the absence of amylin. The cellular viability was accessed after incubation the period using a microplate based MTT assay [16] . Viability was expressed in % of the MTT absorbance at 550 nm in the absence of amylin.
RESULTS
Kinetics of amylin aggregation -We have conducted an amyloid aggregation assay of both
human and murine amylin in phosphate buffer. Both variants show a typical aggregation profile characterized by a lag phase followed by an exponential increase in ThT fluorescence over time converging to a plateau (Fig. 1) . Human amylin reaches the plateau within about 10 h, while no signal of murine amylin ThT binding is detected for up to 27 h, until a rise in ThT fluorescence is observed, reaching about 20 % of the magnitude of the human amylin signal under similar aggregation conditions. The dissimilar magnitude of the total ThT signal may be due to the total amount of ThT bound per total amyloid material, the quantum yield and / or the total amount of amyloid material formed. Besides, these data evidences that both human and murine amylin show a typical kinetic profile of amyloid aggregation as monitored by ThT and that human amylin show a faster aggregation profile compared to murine amylin. Further possible limitation in amyloid aggregation assays of murine amylin may be due to the use of tris buffer, which hampers amylin aggregation [7, 9] .
Morphological and Immunochemical properties of human and murine amylin aggregates -In order to get further insight on the nature of the aggregate material formed by human and murine amylin, we performed a immunoblot assay by using the A11, an antibody sensible to amylin prefibrillar oligomer-like immunoreactive material (OLIM), and the OC, an antibody sensible to amyloid fiber-like immunoreactive material (FLIM) [17] [18] [19] . The products of amylin aggregation assays were adhered onto Formvar films and observed by transmission electron microscopy (TEM). For both human and murine amylin, mature fibrils and oligomers were observed by transmission electron microscopy (TEM), for both 3 days and 7 days incubation ( Fig. 2) . We have found long fibrils mounting twisted fibers, characteristic of amyloid material [20] in both human and murine amylin (Fig. 2) , confirming the existence of amyloid material in the aggregated samples. While both the human and murine amylin aggregates showed response for the A11 (anti-OLIM antibody) at short incubation period, the immunoblot assay revealed OC (anti-FLIM antibody) responsivity at about day 3 of incubation for both human and murine amylin (Fig. 3) . These aggregates were not detectable in both human and murine amylin directly tested from soluble peptide stock solution in DMSO (not shown). Under TEM we could observe the specificity of these antibodies, able to recognize small material assembly and no binding to mature fiber (Fig. 4) .
During dot-blot data acquisition, we observed that the signal for both antibodies in response to murine amylin samples were lower than those used for human amylin, requiring different instrumental setting to compensate for these features. In fact, the amyloid aggregates of murine amylin seem less responsive to ThT [8, 9] . We reasoned whether the typical lack of signal for oligomers in rodents could be an issue of tinctorial responsiveness or a dissimilar antibody titer between human and murine amylin aggregates, a feature also observed for other amylin variants [10] . In fact, such as OLIM could be detected in pancreas of elder humans without diagnosed overt diabetes [21] , although a hyperhormonemic subclinical diabetes condition [22, 23] could be responsible for such outcome. We were able to detect OLIM responsiveness for the A11 in 16-week old mice ( Fig. 5 and Supp. Fig. 1 and Supp Fig. 2) .
These data indicate the responsivity of both human and murine amylin assemblies for the immunodetection by the A11 (anti-OLIM) both in vitro and in biological specimens.
Cellular toxicity of human and murine amylin -
The toxicity of the amylin aggregates was evaluated in insulinome INS-1 cell line by monitoring the MTT reduction assay. Both human and murine amylin were allowed to aggregate for varying time intervals in phosphate buffer at pH 7.4 and further assayed for toxicity. We observed a reduction in the viability of cell as accessed by the MTT assay ( Fig. 6) , both for human and murine amylin. These data indicate that the murine amylin aggregates contain material displaying toxic behavior for the insulinome cell lines, a similar behavior to that observed for human amylin aggregates. Although some authors suggest that oligomers are toxic specimens [12, 17, 24, 25] , for the present moment one cannot assure which fraction of the amyloid aggregates generated in the present study are more likely to behave as toxic agents. Further investigation will require a careful fractioning and extensive structural and toxicological characterization of the material.
DISCUSSION
We have shown here that the product of both human and murine amylin aggregation assay in vitro contain both amyloid fibrils and species reactive to anti-oligomer antibody, and that they present similar toxic pattern to INS-1 insulinome cell line. Moreover, our data demonstrate that OLIM antibody is able to selectively recognize and binding to the islet of nontransgenic swiss mice, suggesting the existence of oligomer-like immunoreactive material in wild-type murine pancreas.
The historical lack of observation of amyloid material in murine models has been interpreted as a lack of the amyloidogenic pathway in these organisms, which has been sustained by the inability of detection of ThT response in aggregation process in vitro. However, recent data have shown that ThT is not an absolute probe for amyloid material, given that murine amylin [8, 9] and puffer-fish amylin [10] and even the more stable amylin analogue pramlintide [7] can form amyloid material, with ThT responsiveness at lower threshold for detection when compared to the product of human amylin aggregation assay.
For over 25 years, the misguided lack of observation of amyloid aggregates both in vitro and in vivo has delineated the conventional wisdom that proline-rich amylin variants do not evolve to amyloid aggregates (Westermark et al. 1990 ). Indeed, several independent groups have reported their lack of detection of amyloid deposits in rodents, prompting for the development of transgenic models overexpressing human amylin. However, as from an analytical perspective, absence of signal is not equal to absence of matter. Classical evaluation of amyloid deposits involved tintorial detection by histochemical techniques [1, 26, 27] , which show low sensitivity to amyloid material from murine amylin [8] . More recently, antibodies anti-oligomer-like and anti-fibril-like immunoreponsive material (OLIM and FLIM, respectivelly) have been developed and tested against a variety of amyloid polypeptides, showing adequate responsiveness [28] [29] .
Our group have shown for the first time that murine amylin does form low and high order oligomers and amyloid fibers in vitro (Palmieri et al. 2013b) . Although the morphologic characteristics of these murine aggregates show typical signatures of amyloid material such as xray diffraction pattern, fibrils on transmission electron microscopy and atomic force microscopy [8, 9] , the tintorial properties of these aggregates were less pronounced when compared to the material obtained from human amylin, limiting the detection of amyloid material from murine amylin. However, we have shown here for the first time to the best of our knowledge that the classical A11 and OC antibodies against OLIM and FLIM are responsive to murine amylin aggregate material, which could be used to specifically detect OLIM in pancreatic islets of nontransgenic mice. These results indicate the potential of murine amylin populating the oligomers in natural abundance in vivo, and the use of immunochemistry in the investigation of such events in non-transgenic murine animals models of amyloid-related pathologies. 
